Therapeutic relevance of altered cytokine expression

Cytokine

Volumn 14, Issue 1, 2001, Pages 1-10

  Kulmatycki, Kenneth M ^a   Jamali, Fakhreddin ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PROPRANOLOL; TUMOR NECROSIS FACTOR ALPHA; VERAPAMIL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGINA PECTORIS; ARTICLE; ASTHMA; CYTOKINE PRODUCTION; GENE OVEREXPRESSION; HEART INFARCTION; HUMAN; INFLAMMATORY DISEASE; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ANGINA; ANIMALIA;

EID: 0035820176     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0827     Document Type: Article

References (134)

1. Leukocyte migration and inflammation
2. Chemokines-chemotactic cytokines that mediate inflammation
3. Cytokines: Overview
4. Crossregulation between Th1 and Th2 cells
5. The production of cytokines by polymorphonuclear neutrophils
6. Bypassing the antigen to control rheumatoid arthritis
7. Sleep a physiologic role for IL-1β and TNF-α
8. Chemokine immunobiology in HIV-1 pathogenesis
9. Delineation of the proinflammatory cytokine cascade in fever induction
10. Tumor necrosis factor in myocardial hypertrophy and ischaemia - An anti-apoptotic perspective
11. The role of cytokines in the failing human heart
12. Role of tumour necrosis factor-α in the progression of heart failure therapeutic implications
13. Basic mechanisms in heart failure: The cytokine hypothesis
14. Cytokines and chemokines in HIV infection: Implications for therapy
15. HIV-1 exposed dentritic cells show increased pro-inflammatory cytokine production but reduced IL-1ra following lipopolysaccharide stimulation
16. CCR5 and CXCR4 chemokine receptor expression and β-chemokine production during early T-cell repopulation induced by highly active anti-retroviral therapy
17. Chemokines and chemokine receptors: Biology and clinical relevance in inflammation and AIDS
18. H2 cell responses
19. Cytokines and allergic diseases: Clinical aspects
20. T-cell subsets (Th1 versus Th2)
21. Biology of IL-5 in health and disease
22. The regulation of IL-12: Its role in infectious, autoimmune, and allergic diseases
23. The role of cytokines and chemokines on tumor progression: A review
24. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
25. Chemokines and their role in tumor growth and metastasis
26. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
27. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction
28. Relation between C-reactive protein levels on admission and pattern of acute myocardial infarction onset
29. C-reactive protein as a cardiovascular risk factor more than an epiphenomenon?
30. C-reactive protein in offspring is associated with the occurrence of myocardial infarction in first-degree relatives
31. Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium
32. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction
33. Cytokine signaling during myocardial infarction: Sequential appearance of IL-1β and IL-6
34. Therapeutic strategies to reduce TNF-α mediated cardiac contractile depression following ischemia and reperfusion
35. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction
36. High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2
37. Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease
38. Factors influencing endothelial cell poliferation in vitro
39. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins
40. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure
41. Enhanced inflammatory response in patients with preinfarction unstable angina
42. Perturbation of the T-cell repertoire in patients with unstable angina
43. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin
44. A tale of two diseases atherosclerosis and rheumatoid arthritis
45. Increased urine interleukin-1 levels in aging
46. Association of interleukin-6 and other biological variables with depression in older people living in the community
47. Serum IL-6 level and the development of disability in older persons
48. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
49. The future role of anti-tumor necrosis factor-α products in the treatment of Crohn's disease
50. Inflammatory bowel disorders
51. Hypothesis on the role of cytokines in peptic ulcer disease
52. Ulcer recurrence cytokines and inflammatory response-dependent process
53. Cytokines and fever
54. IL-6 and IL-1 receptor antagonist in stable angina pectoris and relation of IL-6 to clinical findings in acute myocardial infarction
55. Glial-neuronal interactions in Alzheimer's disease: The potential role of a cytokine cycle in disease progression
56. Interleukin-1β and interleukin-6 are elevated in the cerebral spinal fluid of Alzheimer's and de novo Parkinson's disease patients
57. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis
58. Involvement of cytokines in normal CNS development and neurological diseases: Recent progress and perspectives
59. Role of proinflammatory cytokines in cerebral ischemia: A review
60. Cytokines and cell adhesion molecules in cerebral ischemia
61. The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection
62. Cytokines, signal transduction, and inflammatory demyelination: Review and hypothesis
63. TNF neutralization in MS results of a randomized, placebo-controlled multicenter study
64. The role of tumor necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system
65. Effector pathways in immune mediated central nervous system demyelination
66. Chemokine receptor antagonists
67. Elevated C-reactive protein levels in overweight and obese adults
68. Tumor necrosis factor-α in sera of obese patients: Fall with weight loss
69. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction a potential role for cytokines originating from adipose tissue?
70. Role of tumor necrosis factor-α gene locus in obesity and obesity-associated hypertension in French Canadians
71. Immune activation: The role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states
72. Implications of immune-to-brain communication for sickness and pain
73. Depression, stress and immunological activation: The role of cytokines in depressive disorders
74. Cerebrospinal cytokine levels in patients with acute depression
75. Increased serum interleukin-1-receptor-antagonist concentrations in major depression
76. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression
77. Plasma interleukin-1β and tumor necrosis factor concentrations in obsessive-compulsive disorders
78. Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder
79. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission
80. Elevated circulating levels of IL-6 in schizophrenia
81. Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: Effects of clozapine treatment
82. Polymorphisms of the interleukin-1 gene complex in schizophrenia
83. The effects of psychological stress on leukocyte subset distribution in humans: Evidence of immune activation
84. Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis
85. The mechanism of action of disease-modifying antirheumatic drugs: A review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines
86. Role of cytokines in rheumatoid arthritis
87. Cytokines and autoimmune disorders
88. New insights into the pathogenesis and treatment of rheumatoid arthritis
89. Cytokines in rheumatoid arthritis potential targets for pharmacological, intervention
90. A high plasma concentration of TNF-α is associated with dementia in centenarians
91. The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety
92. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function
93. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment
94. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, Etanercept) in patients with advanced heart failure
95. Kinetics of tumor necrosis factor α in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor α in acute myocardial infarction
96. Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis
97. Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay
98. Effect of experimental diabetes mellitus and arthritis on the pharmacokinetics of hydroxychloroquine enantiomers in rats
99. Effect of inflammatory disease on plasma concentrations of three β-adrenoceptor blocking agents
100. Increased S-verapamil plasma concentration in rheumatic arthritis without increased cardiac effect
101. 1-acid glycoprotein
102. Propranolol pharmacodynamics in ketoprofen treated and untreated adjuvant arthritis
103. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat
104. Increase in antilipoperoxidant activity of plasma as a consequence of an inflammatory reaction induced by subcutaneous turpentine in the rabbit
105. Antagonism of antihypertensive drug therapy by nonsteroidal anti-inflammatory drugs
106. Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration
107. Pharmacodynamics of sotalol enantiomers are influenced by inflammation with no pharmacokinetic consequence
108. Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat
109. 2+ transients
110. 2+ current by IL-1β in rat ventricular myocytes
111. Decreased density of beta-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis
112. Regulation of the beta-receptor-adenylate cyclase system in lymphocytes of allergic patients with asthma: Possible role for protein kinase C in allergen-induced nonspecific refractoriness of adenylate cyclase
113. Altered inotropism in the failing human myocardium
114. The beta-adrenergic receptor kinase: Role in homologous desensitization in S49 lymphoma cells
115. Verapamil decreases lymphocyte protein kinase C activity in humans
116. Nitric oxide signaling: Would you believe that a simple free radical could be a second messenger, autocoid, paracrine substance, neurotransmitter, and hormone?
117. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
118. Sustained plasma TNF-α and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans
119. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: Persistent TNF activation is associated with virologic and immunologic treatment failure
120. Corticosteroid resistance in mild asthma: Markers of persistent inflammation
121. Prostrate carcinoma response to cytotoxic therapy: In vivo resistance
122. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-β
123. Circulating interleukin 6 concentrations and insulin resistance in patients with cancer
124. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
125. Long-term effects of pravastatin on plasma concentration of C-reactive protein
126. Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients altered electrocardiographic and hypotensive responses
127. Medical Research Council trial of treatment of hypertension in older adults: Principal results
128. Are β-blockers efficacious as first-line therapy for hypertension in the elderly?
129. Verapamil pharmacodynamics and disposition in obese hypertensive patients
130. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression
131. The inflammatory response system in treatment-resistant schizophrenia: Increased serum interleukin-6
132. Divergent effect of cyclosporin on Th1/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis
133. Increased expression of multidrug resistance of P-glycoprotein on Th1 cells correlates with drug resistance in rheumatoid arthritis